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The spectrum-effect relationship—a rational
approach for screening effective compounds
from Chinese herbal medicine
Chunsheng ZHU, Bing ZHANG, Zhijian LIN,
Xuejie WANG, Hongjuan NIU
School of Chinese Pharmacy, Beijing University of
Chinese Medicine
Purpose: Introduce a rational method for reﬂecting the
Chinese herbal medicine effective compositions and inter-
nal quality—the spectrum-effect relationship theory, so as
to provide ideas and references about screening the Chinese
herbal medicine effective components, distinguish different
herbal species and truly reﬂect the inner quality of Chinese
herbal medicine.
Methods: We systematically review the application of the
spectrum-effect relationship theory in the research of Chi-
nese herbal medicine, including research mentality, different
chromatographic analysis techniques, data processing tech-
nologies and structure determination.
Results: It is proved that, with the help of the spectrum-
effect relationship, the authenticationand identiﬁcationof the
Chinese herbal medicine can be accurately conducted even if
the concentration of effective components are not very similar
in different samples.
Conclusion: The spectrum-effect relationship is consid-
ered as a potential method to determine active ingredients in
complex mixtures and reﬂect the internal quality of Chinese
herbal medicine.
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Purpose: We performed a systematic review with meta-
analysis for Complementary and Alternative Medicine (CAM)
as deﬁned by the Cochrane Collaboration in hepatitis B and C.
Methods: A computerized search of databases (Cochrane
Library, Medline, PsychINFO, and Scopus) through June 2013
was performed. We screened the reference sections of original
studies and systematic reviews in English language for CAM in
hepatitis B and C. Randomized controlled trials (RCT) compar-
ing treatment to controls were assessed by the Cochrane risk
of bias tool. Where possible, meta-analyses were performed
using odds ratios (OR) with 95% conﬁdence intervals (CI).
Results: A total of 59 RCT were found, 12 in hepatitis B, 46
in hepatitis C and one in both. 23 studies could be included
in a meta-analysis. The risk of bias was heterogeneous in the
included studies. In hepatitis B meta-analysis was performed
for cyanidanol vs placebo. No effect on the biochemical mark-
ers (p=0.55) but a signiﬁcant effect on viral response (2 studies;
n=310; OR = 5.04; 95%CI 1.76-14.44; p=0.003) could be shown. In
hepatitis C meta-analysis showed a signiﬁcant effect on bio-
chemicalmarkers in vitaminDvsplacebo (2 studies; n=122;OR
= 7.94; 95%CI 2.86-2 2.03; p<0.0001) and on biochemical mark-
ers (5 studies; n=347; OR=1.87; 95%CI 1.20-2.90; p=0.0005) as
well as viral response (6 studies; n=380; OR=2.09; 95%CI 1.34-
3.27; p=0.001) in phlebotomie. No signiﬁcant effect could be
shown for vitaminCandE (2 studies; n=61), omega-3-fatty acid
(2 studies; n=62), silymarin (2 studies, n=293), zinc (5 studies,
n=256) or CH-100 (2 studies; n=131).
Conclusion: The average methodological quality of the
identiﬁed studies was heterogeneous. Best evidence was
found for cyanidanol in the treatment hepatitis B and vitamin
D and phlebotomie in the treatment of hepatitis C.
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Purpose: Chinese herbal medicine (CHM) has been increas-
ingly used as an adjuvant treatment for multi-drug resistant
tuberculosis (MDR-TB) in China. To inform clinical practice,
we performed a systematic review on the beneﬁcial effect and
safety of CHM for MDR-TB.
Methods: We systematically searched the six electronic
databases for randomised clinical trials (RCTs) of CHM plus
chemotherapy for MDR-TB. RevMan 5.2 software was used for
data analyseswith effect estimates presented as risk ratio (RR)
with 95% conﬁdence interval (CI).
Results: 28 RCTs involving 3085 participants with MDR-
TB were included. The methodological quality was generally
poor in terms of risk of bias. Meta-analyses favoured CHM
plus chemotherapy on sputum bacteriological conversion rate
compared with chemotherapy alone after initiation of treat-
ment (6th mos: RR 1.29, 95% CI 1.14 to 1.46, n=11; 12th mos:
RR 1.38, 95% CI 1.19 to 1.59, n=5; 18th mos: RR 1.19, 95% CI
1.11 to 1.28, n=7). Compared with chemotherapy alone, meta-
analysis showedbeneﬁt fromCHMplus chemotherapy on lung
